- Trials with a EudraCT protocol (123)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
123 result(s) found for: Pulmonary Edema.
Displaying page 1 of 7.
EudraCT Number: 2020-001244-26 | Sponsor Protocol Number: COV-2-SOLNATIDE-20 | Start Date*: 2020-04-11 | ||||||||||||||||
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna, Vienna Austria | ||||||||||||||||||
Full Title: COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial. | ||||||||||||||||||
Medical condition: Pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-003855-47 | Sponsor Protocol Number: AP301-II-002 | Start Date*: 2018-02-27 | ||||||||||||||||
Sponsor Name:Apeptico Forschung und Entwicklung GmbH | ||||||||||||||||||
Full Title: Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability oedema in patients with moderate-to-severe ARDS - a randomised, placebo-controlle... | ||||||||||||||||||
Medical condition: pulmonary permeability oedema in patients with moderate-to-severe ARDS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Ongoing) DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005166-22 | Sponsor Protocol Number: M2018 | Start Date*: 2018-03-26 | |||||||||||
Sponsor Name:UK für Anästhesiologie und allgemeine Intensivmedizin | |||||||||||||
Full Title: Effect of acetazolamide on the incidence of high altitude pulmonary edema at 4559 m | |||||||||||||
Medical condition: Healthy volunteer trial at 4459m to investigate the effect of acetazolamide on the incidence of high altitude pulmonary edema. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003822-96 | Sponsor Protocol Number: AC-055G201 | Start Date*: 2014-05-08 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||||||||||||||||||
Full Title: A prospective, multicenter, double-blind, randomized, placebo-controlled, parallel group, 12-week study to evaluate the safety and tolerability of macitentan in subjects with combined pre- and post... | ||||||||||||||||||
Medical condition: Combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left ventricular dysfunction. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) CZ (Completed) AT (Completed) BE (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001613-33 | Sponsor Protocol Number: BRIDGE | Start Date*: 2014-05-13 | ||||||||||||||||
Sponsor Name:Thoraxclinic at the University of Heidelberg | ||||||||||||||||||
Full Title: Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure | ||||||||||||||||||
Medical condition: Pulmonary Hypertension and Left Heart Failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-001306-87 | Sponsor Protocol Number: CANc/CHF14/TIF | Start Date*: 2005-06-13 | |||||||||||
Sponsor Name:TAKEDA | |||||||||||||
Full Title: EFFECTS OF CANDESARTAN CILEXETIL VS STANDARD THERAPY ON SERUM LEVELS OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS SUFFERING FROM CHRONIC HEART FAILURE WITH DEPRESSED AND PRESERVED SYSTOLIC FUNCTION | |||||||||||||
Medical condition: CHRONIC HEART FAILURE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003688-37 | Sponsor Protocol Number: KKS-243 | Start Date*: 2018-07-06 | ||||||||||||||||
Sponsor Name:Philipps-Universität Marburg | ||||||||||||||||||
Full Title: Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION), A randomized, placebo-controll... | ||||||||||||||||||
Medical condition: Combined post- and pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000771-24 | Sponsor Protocol Number: CXL-1427-02 | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:Cardioxyl Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6-Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients with Systolic Heart Failure | |||||||||||||
Medical condition: Heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001889-16 | Sponsor Protocol Number: CLB-2006 | Start Date*: 2006-03-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Use of clembuterol in patients affected by valvular hearth disease and dilated cardiomyopathy | |||||||||||||
Medical condition: No healthy subjects (patients affected by valvular hearth disease and dilated cardiomyopathy) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006644-27 | Sponsor Protocol Number: CARR-ARDS-2021 | Start Date*: 2023-02-28 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | |||||||||||||
Full Title: Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study. | |||||||||||||
Medical condition: Acute respiratory distress syndrome (ARDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001612-25 | Sponsor Protocol Number: REP0122 | Start Date*: 2022-10-12 | |||||||||||
Sponsor Name:DOMPé FARMACEUTICI S.P.A. | |||||||||||||
Full Title: Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with ... | |||||||||||||
Medical condition: Acute Respiratory Distress Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001199-31 | Sponsor Protocol Number: 57231 | Start Date*: 2017-03-20 |
Sponsor Name: | ||
Full Title: Improving treatment of right ventricular failure in pulmonary hypertension patients. | ||
Medical condition: End stage right ventricular failure in pulmonary hypertension patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004706-22 | Sponsor Protocol Number: ImlifidARDSe.01 | Start Date*: 2023-02-17 | ||||||||||||||||||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | ||||||||||||||||||||||||||||
Full Title: Imlifidase in ANCA-associated vasculitis | ||||||||||||||||||||||||||||
Medical condition: Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis with severe diffuse alveolar hemorrhage | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000775-17 | Sponsor Protocol Number: PI11-0143 | Start Date*: 2012-11-21 | |||||||||||
Sponsor Name:Jesús Villar Hernández | |||||||||||||
Full Title: A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients with the Acute Respiratory Distress Syndrome | |||||||||||||
Medical condition: Acute respiratory distress syndrome (ARDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005306-25 | Sponsor Protocol Number: Pioneer | Start Date*: 2021-09-15 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: PIrfenidone to prevent fibrOsis in ARDS. A RaNdomizEd controllEd tRial (PIONEER) GR-2019-12371063 | |||||||||||||
Medical condition: Acute respiratory distress syndrome (ARDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005394-66 | Sponsor Protocol Number: ESR-20-21070 | Start Date*: 2022-02-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE | |||||||||||||
Full Title: Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction | |||||||||||||
Medical condition: heart failure with left ventricular ejection fraction <50% | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004442-16 | Sponsor Protocol Number: cro524 | Start Date*: 2006-11-29 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Modulation of lung injury complicating lung resection | |||||||||||||
Medical condition: Acute respiratory distress syndrome, Acute Lung Injury, Ventilator-Induced Lung Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002022-20 | Sponsor Protocol Number: NL61945.029.17 | Start Date*: 2017-07-27 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effect of inspiratory oxygen fraction on the ratio of partial arterial oxygen pressure and inspiratory oxygen fraction (PaO2/FiO2 ratio) in mechanically ventilated patients with and without mil... | |||||||||||||
Medical condition: We investigate the PaO2/FiO2 ratio in patients without and with mild to moderate ARDS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020403-75 | Sponsor Protocol Number: ACEmeVent-Pilot | Start Date*: 2011-10-24 | ||||||||||||||||
Sponsor Name:Universität Leipzig | ||||||||||||||||||
Full Title: ACE inhibitor for lung protection during mechanical Ventilation for acute lung injury - pilot trial | ||||||||||||||||||
Medical condition: acute lung injury, ALI/ARDS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-002494-28 | Sponsor Protocol Number: 6 | Start Date*: 2023-05-18 | |||||||||||
Sponsor Name:Consorcio Centro de Investigacion Biomedica en Red, (CIBER) | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of intravenous metoprolol in patients with Acute Respiratory Distress Syndrome (ARDS) | |||||||||||||
Medical condition: Intensive Care Unit patients with Acute Respiratory Distress Syndrome (ARDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.